PCVX β€” VAXCYTE INC

Ownership history in Fiera Capital Corp  Β·  3 quarters on record

This page tracks every 13F SEC filing in which Fiera Capital Corp reported a position in VAXCYTE INC (PCVX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.05% (2025 Q1)
πŸ“Š Avg. % of fund
0.04%
πŸ“… First filed
2025 Q1
πŸ“… Last filed
2025 Q3
⏱ Quarters held
3

Position Intelligence

Fiera Capital Corp Γ— PCVX AI Analytics

πŸ“‰ Fiera Capital Corp underperformed the S&P 500 by –44.0% annually on this PCVX position. Average cost basis: $37.76. Maximum drawdown during holding period: –13.9%.

πŸ“ˆ Position Alpha vs SPY
-44.0%
annualised excess return

❌ Significantly underperformed the S&P 500 by 44.0% ann.
2 quarters analyzed

πŸ’° Entry Quality
$37.76
-4.6% vs current ($36.02)

Best entry: $37.76 (2025 Q1)  Β·  Worst: $37.76 (2025 Q1)

πŸ›‘οΈ Drawdown Resilience
–13.9%
max drawdown while held

πŸ’Ž No drawdown exceeding 20% during the holding period β€” exceptionally stable.

πŸ’ͺ Fund Conviction
33%
buy-side decisions

1 add Β· 2 trims. Bought during 0 of 1 down-price quarters. πŸ“‰ Predominantly trimming β€” distribution phase.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.04% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    PCVX price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 3 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 345,852 -7,990 -2.3% 0.04% $12.5M $36.02
2025 Q2 REDUCED 353,842 -5,360 -1.5% 0.04% $11.5M $32.51
2025 Q1 INITIATED 359,202 β€” β€” 0.05% $13.6M $37.76

🏒 Other funds also holding PCVX

As of 2025 Q4 β€” sorted by position size

Pivotal bioVenture Partners Investment Advisor LLC 3Y 24.48% Kynam Capital Management, LP 3Y 8.61% Saturn V Capital Management LP 3Y 6.77% Caligan Partners LP 3Y 6.48% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 5.07% Paradigm Biocapital Advisors LP 3Y 4.79% Elmind Capital, LP 3.97% Deep Track Capital, LP 3Y 3.29% Novo Holdings A/S 3Y 7Y 3.28% Eversept Partners, LP 3Y 7Y 2.78%
← Back to Fiera Capital Corp Holdings